Canby-Hagino Edith D, Swanson Gregory P, Crawford E David, Basler Joseph W, Hernandez Javier, Thompson Ian M
Department of Urology, University of Texas Health Sciences Center, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA.
Curr Urol Rep. 2005 May;6(3):183-9. doi: 10.1007/s11934-005-0006-5.
Data from well-designed, prospective clinical trials are lacking to support treatment of primary tumor in men diagnosed with metastatic prostate cancer. However, a growing body of evidence suggests that treatment of the primary tumor may enhance cancer control and survival in some men. This evidence is examined and recommendations are made for identifying patients with metastatic prostate cancer who may benefit from definitive treatment of the prostate tumor.
缺乏来自设计良好的前瞻性临床试验的数据来支持对诊断为转移性前列腺癌的男性原发性肿瘤进行治疗。然而，越来越多的证据表明，对原发性肿瘤的治疗可能会增强某些男性的癌症控制并提高生存率。本文对这一证据进行了研究，并就如何识别可能从前列腺肿瘤确定性治疗中获益的转移性前列腺癌患者提出了建议。
